Organigram (OGI) Scheduled to Post Quarterly Earnings on Tuesday

Organigram (TSE:OGI – Get Rating) will be announcing its earnings results after the market closes on Tuesday, April 11th. Analysts expect the company to announce earnings of C($0.02) per share for the quarter.

Organigram (TSE:OGI – Get Rating) last announced its earnings results on Thursday, January 12th. The company reported C($0.01) EPS for the quarter, beating the consensus estimate of C($0.02) by C$0.01. The company had revenue of C$43.32 million during the quarter, compared to the consensus estimate of C$44.43 million. Organigram had a negative net margin of 4.82% and a negative return on equity of 1.53%.

Get Organigram alerts:

Organigram Price Performance

OGI opened at C$0.82 on Monday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.62 and a current ratio of 4.71. The firm has a market cap of C$257.37 million, a P/E ratio of -41.00, a PEG ratio of 0.42 and a beta of 1.36. Organigram has a fifty-two week low of C$0.81 and a fifty-two week high of C$2.29. The firm has a 50-day moving average of C$1.00 and a 200 day moving average of C$1.17.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on OGI shares. Alliance Global Partners lowered their price objective on shares of Organigram from C$1.50 to C$1.30 in a research report on Friday, January 13th. Jefferies Financial Group reduced their target price on shares of Organigram from C$2.00 to C$1.80 in a report on Tuesday, February 28th. Finally, Stifel Nicolaus raised shares of Organigram from a “hold” rating to a “buy” rating in a research report on Friday, January 13th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of C$2.03.

About Organigram

(Get Rating)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates.

Further Reading

• MarketBeat Week in Review – 4/3 – 4/7
• Costco Sales Disappoint, Markets Are Missing This Upside Driver
• First Republic Bank Is A Speculative Play, Here’s Why
• The WD-40 Company Bottoms With Reversal In Sight 
• 3 Low-Cost Stock ETFs That Are Crushing It This Year

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.